Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Solomon

Showing results (171-180 of 1,422) with videos related to

Pageof 143
Sort By:
JAMA Cardiology|August 14, 2020
Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection FractionThomas A Gaziano, Gregg C Fonarow, Eric J Velazquez, et al.
Circulation. Heart Failure|May 18, 2025
Late-Life Echocardiographic Effects of the Amyloidogenic p.V142I Transthyretin VariantVishal N Rao, Brian L Claggett, Michel G Khouri, et al.
Heart Rhythm|February 28, 2006
Association of QRS duration and outcomes after myocardial infarction: the VALIANT trialLakshminarayan Yerra, Nagesh Anavekar, Hicham Skali, et al.
European Journal of Heart Failure|September 11, 2012
Utility of lung ultrasound in predicting pulmonary and cardiac pressuresElke Platz, AnnMarie Lattanzi, Chioma Agbo, et al.
Circulation|May 19, 2004
Right ventricular enlargement on chest computed tomography: prognostic role in acute pulmonary embolismRene Quiroz, Nils Kucher, U Joseph Schoepf, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 10, 2021
Weight changes in heart failure with preserved ejection fraction: findings from TOPCATJoão Pedro Ferreira, Patrick Rossignol, Brian L Claggett, et al.
Circulation|March 29, 2018
Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical TrialsBrian Claggett, Stuart Pocock, L J Wei, et al.
Circulation|January 15, 2019
Response by Claggett et al to Letter Regarding Article, "Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical Trials"Brian Claggett, Stuart Pocock, L J Wei, et al.
European Journal of Heart Failure|May 16, 2020
COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new diseaseDaniela Tomasoni, Leonardo Italia, Marianna Adamo, et al.
European Journal of Heart Failure|November 5, 2014
Impact of lowering pulmonary vascular resistance on right and left ventricular deformation in pulmonary arterial hypertensionGabriela Querejeta Roca, Patricia Campbell, Brian Claggett, et al.
Pageof 143

Showing results (171-180 of 1,422) with videos related to

Sort By:
Pageof 143
JAMA Cardiology|August 14, 2020
Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection FractionThomas A Gaziano, Gregg C Fonarow, Eric J Velazquez, et al.
Circulation. Heart Failure|May 18, 2025
Late-Life Echocardiographic Effects of the Amyloidogenic p.V142I Transthyretin VariantVishal N Rao, Brian L Claggett, Michel G Khouri, et al.
Heart Rhythm|February 28, 2006
Association of QRS duration and outcomes after myocardial infarction: the VALIANT trialLakshminarayan Yerra, Nagesh Anavekar, Hicham Skali, et al.
European Journal of Heart Failure|September 11, 2012
Utility of lung ultrasound in predicting pulmonary and cardiac pressuresElke Platz, AnnMarie Lattanzi, Chioma Agbo, et al.
Circulation|May 19, 2004
Right ventricular enlargement on chest computed tomography: prognostic role in acute pulmonary embolismRene Quiroz, Nils Kucher, U Joseph Schoepf, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 10, 2021
Weight changes in heart failure with preserved ejection fraction: findings from TOPCATJoão Pedro Ferreira, Patrick Rossignol, Brian L Claggett, et al.
Circulation|March 29, 2018
Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical TrialsBrian Claggett, Stuart Pocock, L J Wei, et al.
Circulation|January 15, 2019
Response by Claggett et al to Letter Regarding Article, "Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical Trials"Brian Claggett, Stuart Pocock, L J Wei, et al.
European Journal of Heart Failure|May 16, 2020
COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new diseaseDaniela Tomasoni, Leonardo Italia, Marianna Adamo, et al.
European Journal of Heart Failure|November 5, 2014
Impact of lowering pulmonary vascular resistance on right and left ventricular deformation in pulmonary arterial hypertensionGabriela Querejeta Roca, Patricia Campbell, Brian Claggett, et al.
Pageof 143